NVOS OTC
Novo Integrated Sciences, Inc.
1W: -84.6%
1M: +0.0%
3M: -82.9%
YTD: -77.8%
1Y: -88.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$13M
+5.7% ▲
5Y CAGR: +7.1%
Gross Profit
$6M
+15.9% ▲
5Y CAGR: +10.3%
Operating Income
-$8M
+2.8% ▲
Net Income
-$16M
-22.1% ▼
EPS (Diluted)
$-0.90
+30.8% ▲
EBITDA
-$10M
-72.3% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $8M | $9M | $12M | $13M | $13M |
| YoY Growth | -16.6% | +18.4% | +26.1% | +7.1% | +5.7% |
| Cost of Revenue | $5M | $5M | $7M | $8M | $8M |
| Gross Profit | $3M | $4M | $5M | $5M | $6M |
| Gross Margin | 38.9% | 41.1% | 40.9% | 39.4% | 43.2% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $7M | $8M | $14M | $14M | $14M |
| Operating Expenses | $7M | $8M | $14M | $14M | $14M |
| Operating Income | -$4M | -$4M | -$10M | -$9M | -$8M |
| Operating Margin | -54.2% | -45.9% | -81.7% | -68.0% | -62.5% |
| Interest Expense | $157K | $165K | $8M | $5M | -$652K |
| Income Before Tax | -$5M | -$4M | -$33M | -$13M | -$16M |
| Tax Expense | $0 | $0 | -$22K | $0 | $0 |
| Net Income | -$5M | -$4M | -$33M | -$13M | -$16M |
| Net Margin | -62.5% | -48.0% | -279.9% | -105.1% | -121.3% |
| EPS (Diluted) | $-2.13 | $-1.80 | $-11.28 | $-1.30 | $-0.90 |
| EBITDA | -$3M | -$3M | -$22M | -$6M | -$10M |
| Shares Outstanding | 2M | 2M | 3M | 10M | 18M |